Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:647684.
doi: 10.1155/2012/647684. Epub 2012 Jun 27.

Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors

Faruk Tas  1
Affiliations

Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors

Faruk Tas. J Oncol. 2012.

Abstract

Metastatic melanoma (MM) is a fatal disease with a rapid systemic dissemination. This study was conducted to investigate the metastatic behavior, timing, patterns, survival, and influencing factors in MM. 214 patients with MM were evaluated retrospectively. Distant metastases (82%) were the most frequent for patients initially metastatic. The median and 1-year survival rates of initially MM patients were 10 months and 41%, respectively. The median time to metastasis for patients with localized disease was 28 months. The timing of appearance of metastases varied minimally; however, times to metastases for distant organs varied greatly. For the first metastatic pathway, more than half of the primary metastases were M1A (57%). These findings were in contrast to the results compared with those with metastatic in diagnosis (P < 0.001). The median and 1-year survival rates of all patients were 12 months and 49%, respectively. Outcome was higher in M1A than visceral metastases (P < 0.001). In conclusion, the fact that over half of all recurrences/metastases occurred within 3 years urges us to concentrate follow-up in the early time periods following diagnosis. Because the clinical behavior of MM is variable, the factors for survival consisting of site and number of metastases should be emphasized.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival rates of metastatic patients diagnosed at presentation. S: only single-organ metastasis; M: mixed with other distal organ metastases.
Figure 2
Figure 2
Time periods to metastases in metastatic patients with diagnosed during follow-up.
Figure 3
Figure 3
Postmetastatic survival values in metastatic patients diagnosed during follow-up.
Figure 4
Figure 4
Intervals from the date of first metastases to the date of second metastases in metastatic patients who presented twice with metastatic disease.
Figure 5
Figure 5
Intervals between initial metastases and secondary metastases.
Figure 6
Figure 6
The distributions of M stages depend on time of metastasis presentation (%).
Figure 7
Figure 7
The distributions of distant organs depend on time of metastasis presentation (%).
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer Journal for Clinicians. 2009;59(4):225–249. - PubMed
    1. Soong S-J, Harrison RA, McCarthy WH, Urist MM, Balch CM. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. Journal of Surgical Oncology. 1998;67(4):228–233. - PubMed
    1. Gershenwald JE, Balch CM, Soong SJ, Thompson JF. Prognostic factors and natural history of melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous Melanoma. 5th edition. St. Louis, Mo, USA: Quality Medical Publishing; 2009. pp. 35–64.
    1. Atkins MB, Hauschild A, Wahl RL, Balch CM. Diagnosis of Stage IV melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous Melanoma. 5th edition. St. Louis, Mo, USA: Quality Medical Publishing; 2009. pp. 573–602.
    1. Meier F, Will S, Ellwanger U, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. British Journal of Dermatology. 2002;147(1):62–70. - PubMed

LinkOut - more resources